Yes, lidocaine is an antiarrhythmic drug. It belongs to a category called Class Ib antiarrhythmics, and it has been one of the primary treatments for dangerous ventricular heart rhythms for several decades. Most people know lidocaine as a local anesthetic used in dental work or minor procedures, but when given intravenously, it works directly on the heart’s electrical system to correct life-threatening rhythm problems.
How Lidocaine Works on the Heart
Lidocaine targets sodium channels in heart muscle cells. These channels control the flow of sodium ions that trigger each heartbeat’s electrical impulse. Specifically, lidocaine binds to sodium channels that are in their inactive state, which means it preferentially affects cells that are firing too rapidly or abnormally. This selective binding is what makes it useful against arrhythmias without shutting down normal heart rhythm entirely.
The drug shortens the duration of each electrical cycle in the ventricles (the heart’s lower chambers) while making the cells take slightly longer to become ready to fire again relative to that shortened cycle. The net effect is that the heart becomes less susceptible to the rapid, chaotic electrical signals that cause dangerous ventricular rhythms. Healthy tissue with a normal firing rate is largely unaffected, which is why lidocaine can suppress an arrhythmia without dramatically slowing an otherwise normal heartbeat.
Which Arrhythmias It Treats
Lidocaine is used specifically for ventricular arrhythmias, the most dangerous type of abnormal heart rhythm. These include ventricular fibrillation (where the lower chambers quiver uselessly instead of pumping blood) and ventricular tachycardia (where they beat dangerously fast). It is not used for arrhythmias originating in the upper chambers of the heart, like atrial fibrillation.
Current guidelines from major cardiology organizations position lidocaine in several specific scenarios:
- Cardiac arrest from ventricular fibrillation or ventricular tachycardia that hasn’t responded to CPR, defibrillation, and vasopressor medications
- Shock-refractory ventricular fibrillation or tachycardia, meaning the rhythm persists after at least one attempt at defibrillation
- Recurrent polymorphic ventricular tachycardia or fibrillation during a heart attack, when beta-blockers or amiodarone haven’t worked or can’t be used
- Stable monomorphic ventricular tachycardia in patients with structural heart disease, as a second-line option
Lidocaine vs. Amiodarone
For years, amiodarone was considered the go-to antiarrhythmic during cardiac arrest. A 2018 update to the American Heart Association’s advanced cardiac life support guidelines changed that picture, placing lidocaine on equal footing. Providers can now choose either amiodarone or lidocaine for shock-refractory ventricular fibrillation or pulseless ventricular tachycardia. In practice, this means both drugs are considered reasonable options in the most critical cardiac emergencies.
European guidelines from the European Society of Cardiology take a slightly more conservative view, listing lidocaine as a second-line therapy for ventricular arrhythmias during acute coronary syndrome. The Canadian position statement gives lidocaine a strong recommendation for shock-refractory cases and as a backup to other drugs for stable ventricular tachycardia. So while the exact ranking varies by country and guideline, lidocaine remains a well-established tool in emergency cardiac care.
How It Is Given
When used as an antiarrhythmic, lidocaine is delivered intravenously, not as a local injection. An IV bolus acts very rapidly, which is critical in emergency settings. The typical approach involves a loading dose of 1 to 2 mg per kilogram of body weight, followed by a continuous infusion of 1 to 2 mg per kilogram per hour to maintain therapeutic levels in the blood.
The liver is responsible for breaking down lidocaine, and the drug has a half-life of roughly 1.5 to 2 hours. This relatively short duration means its effects wear off quickly if the infusion is stopped, which gives clinicians close control over the treatment. However, the half-life can extend significantly in people with liver disease or heart failure, because both conditions reduce the liver’s ability to process the drug efficiently.
Risks and Side Effects
The same sodium channel blocking that makes lidocaine effective against arrhythmias also creates risk if blood levels climb too high. This is known as local anesthetic systemic toxicity, or LAST, and it primarily affects the brain and the cardiovascular system.
Early warning signs tend to involve the nervous system: a metallic taste in the mouth, numbness around the lips, ringing in the ears, confusion, agitation, slurred speech, or hallucinations. Seizures are the most common serious neurological sign. If toxicity progresses further, cardiovascular symptoms can develop, including dangerously low blood pressure, abnormally slow or fast heart rate, and, paradoxically, the very arrhythmias the drug is meant to treat. In severe cases, LAST can lead to cardiac arrest or respiratory failure.
The risk of toxicity is higher in patients with heart failure or liver impairment, since the drug clears more slowly from their systems. Careful monitoring of infusion rates and attention to early neurological symptoms are the primary safeguards.
Why It’s Not Used More Broadly
Despite its long track record, lidocaine occupies a narrower role today than it did in past decades. It can only be given intravenously for arrhythmia management, which limits its use to hospital and emergency settings. It has no oral formulation for ongoing rhythm control. Its short half-life makes it impractical for long-term use. And because it acts selectively on ventricular tissue, it has no role in treating the more common supraventricular arrhythmias like atrial fibrillation or atrial flutter.
Still, lidocaine remains a critical option when other antiarrhythmics fail or are contraindicated. Its rapid onset, predictable metabolism, and decades of clinical experience keep it firmly in the emergency toolkit for the most dangerous heart rhythms a person can experience.